Detalhe da pesquisa
1.
HDX-MS study on garadacimab binding to activated FXII reveals potential binding interfaces through differential solvent exposure.
MAbs
; 15(1): 2163459, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36628468
2.
Increased potency of recombinant VWF D'D3 albumin fusion proteins engineered for enhanced affinity for coagulation factor VIII.
J Thromb Haemost
; 19(11): 2710-2725, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34333849